(2-(2-(2-((2-bromoacetyl)amino)ethoxy)ethoxy)ethoxy)acetic acid

(2-(2-(2-((2-bromoacetyl)amino)ethoxy)ethoxy)ethoxy)acetic acid Suppliers list

Company Name:	Beijing Jin Ming Biotechnology Co., Ltd.
Tel:	010-60605840 15801484223
Email:	psaitong@jm-bio.com
Products Intro:	Product Name:Bromoacetamide-PEG3-C1-acid CAS:173323-22-3 Package:100mg;250mg;500mg Remarks: 试剂级

Company Name:	Shanghai Zhiyun Biotechnology Co., Ltd
Tel:	13119135307
Email:	cuichengbio@163.com
Products Intro:	Product Name:Bromoacetamide-PEG3-C1-acid CAS:173323-22-3 Purity:95-99% Package:g;mg;kg

(2-(2-(2-((2-bromoacetyl)amino)ethoxy)ethoxy)ethoxy)acetic acid Basic information

Product Name:	(2-(2-(2-((2-bromoacetyl)amino)ethoxy)ethoxy)ethoxy)acetic acid
Synonyms:	(2-(2-(2-((2-bromoacetyl)amino)ethoxy)ethoxy)ethoxy)acetic acid;Acetic acid, 2-[2-[2-[2-[(2-bromoacetyl)amino]ethoxy]ethoxy]ethoxy]-;Bromoacetamide-PEG3-C1-acid
CAS:	173323-22-3
MF:	C10H18BrNO6
MW:	328.16
EINECS:
Product Categories:
Mol File:	173323-22-3.mol

(2-(2-(2-((2-bromoacetyl)amino)ethoxy)ethoxy)ethoxy)acetic acid Chemical Properties

Safety Information

MSDS Information

(2-(2-(2-((2-bromoacetyl)amino)ethoxy)ethoxy)ethoxy)acetic acid Usage And Synthesis

Biological Activity	Bromoacetamide-PEG3-C1-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1]
References	[1]. An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562

(2-(2-(2-((2-bromoacetyl)amino)ethoxy)ethoxy)ethoxy)acetic acid Preparation Products And Raw materials

Tag:(2-(2-(2-((2-bromoacetyl)amino)ethoxy)ethoxy)ethoxy)acetic acid(173323-22-3) Related Product Information

Login